BNP and NT-proBNP cutoffs of 622 pg/mL and 4000 pg/mL optimally predicted short-term mortality in patients with sepsis, with AUCs of 0.766 and 0.787, respectively.
Meta-Analysis (n=3,508)
Do BNP and NT-proBNP levels predict short-term mortality in adult patients with sepsis?
BNP and NT-proBNP cutoffs of 622 pg/mL and 4000 pg/mL, respectively, optimally predicted short-term mortality in patients with sepsis, though limited by population heterogeneity.
Effect estimate: AUC 0.766 for BNP, AUC 0.787 for NT-proBNP (95% CI 0.734-0.797 for BNP, 0.766-0.809 for NT-proBNP)
Data are conflicting regarding the optimal cutoffs of B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) to predict short-term mortality in patients with sepsis. We conducted a comprehensive search of several databases (MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Scopus) for English-language reports of studies evaluating adult patients with sepsis, severe sepsis, and septic shock with BNP/NT-proBNP levels and short-term mortality (intensive care unit, in-hospital, 28-day, or 30-day) published from January 1, 2000, to September 5, 2017. The average values in survivors and nonsurvivors were used to estimate the receiver operating characteristic curve (ROC) using a parametric regression model. Thirty-five observational studies (3508 patients) were included (median age, 51-75 years; 12%-74% males; cumulative mortality, 34.2%). A BNP of 622 pg/mL had the greatest discrimination for mortality (sensitivity, 0.695 95% CI, 0.659-0.729; specificity, 0.907 95% CI, 0.810-1.003; area under the ROC, 0.766 95% CI, 0.734-0.797). An NT-proBNP of 4000 pg/mL had the greatest discrimination for mortality (sensitivity, 0.728 95% CI, 0.703-0.753; specificity, 0.789 95% CI, 0.710-0.867; area under the ROC, 0.787 95% CI, 0.766-0.809). In prespecified subgroup analyses, identified BNP/NT-proBNP cutoffs had higher discrimination if specimens were obtained 24 hours or less after admission, in patients with severe sepsis/septic shock, in patients enrolled after 2010, and in studies performed in the United States and Europe. There was inconsistent adjustment for renal function. In this hypothesis-generating analysis, BNP and NT-proBNP cutoffs of 622 pg/mL and 4000 pg/mL optimally predicted short-term mortality in patients with sepsis. The applicability of these results is limited by the heterogeneity of included patient populations.
Vallabhajosyula et al. (Wed,) conducted a meta-analysis in Sepsis, severe sepsis, and septic shock (n=3,508). B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) was evaluated on Short-term mortality (AUC 0.766 for BNP, AUC 0.787 for NT-proBNP, 95% CI 0.734-0.797 for BNP, 0.766-0.809 for NT-proBNP). BNP and NT-proBNP cutoffs of 622 pg/mL and 4000 pg/mL optimally predicted short-term mortality in patients with sepsis, with AUCs of 0.766 and 0.787, respectively.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: